申请人:Applied Research Systems ARS Holding N.V.
公开号:EP1110957A1
公开(公告)日:2001-06-27
The present invention is related to benzazole derivatives according to formula I
wherein
X is O, S or NR0,
G is selected from the group comprising or consisting of unsubstituted or substituted aryl or heteroaryl substituents, unsubstituted or substituted 3-8-membered saturated or unsaturated ring systems containing at least one heteroatom selected from N, O or S; said 3-8-membered ring system may be fused with a substituted or unsubstituted aryl or heteroaryl system thus providing a bicyclic system;
notably for use as pharmaceutically active compounds. Said benzazole derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK2 and/or 3. The present invention is furthermore related to certain novel benzazole derivatives of formula I.
本发明涉及公式I中的苯并咪唑衍生物,其中X为O、S或NR0,G选自包括或由未取代或取代的芳基或杂芳基取代基,含有至少一个选自N、O或S的杂原子的未取代或取代的3-8元饱和或不饱和环系统的未取代或取代的3-8元环系统;该3-8元环系统可以与取代或未取代的芳基或杂芳基系统融合,从而提供一个双环系统;特别适用于作为药物活性化合物。所述苯并咪唑衍生物是JNK途径的有效调节剂,它们特别是JNK2和/或3的有效和选择性抑制剂。本发明还涉及公式I的某些新型苯并咪唑衍生物。